Our results are consistent with the results of Määttä et al. [36] who observed increased levels of TIMP-1 in the course of ovarian cancer, although the tested group was considerably smaller (22 cases) and composed of serous, mucinous and others malignant ovarian tumors. Here, TIMP1 is linked to ovarian cancer.